Portfolio Company · Operating Co.

Prolong Pharmaceuticals

Biopharmaceutical · Website

Prolong Pharmaceuticalsbacked byTarsadia Investments

CurrentBiopharmaceutical

Company Snapshot

Prolong Pharmaceuticals is a biopharmaceutical portfolio company held by Tarsadia Investments. Profile compiled from public sources; submit updates to extend the public record.

SectorBiopharmaceutical

Parent PE firmTarsadia Investments

Ownership statusCurrent

WebsiteVisit ↗

Ownership Context

Prolong Pharmaceuticals is a current portfolio company of Tarsadia Investments. Public coverage of this company is grouped under its parent firm's profile.

Sources

https://tarsadia.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Prolong Pharmaceuticals and does not provide investment advice.

Other portfolio companies of Tarsadia Investments

Amneal Pharmaceuticals

Pharmaceuticals

Asana Biosciences

Life Sciences / Biotech

AvantStay

Real Estate / Hospitality

Citadel Access Solutions

Commercial Services / Access Control

ClinTrial Research

Healthcare Services

See the full Tarsadia Investments portfolio.